Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-09

Clinical Trial Update: Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chloroquine diphosphate for prevention of COVID-19/SARS-CoV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine diphosphate (chloroquine diphosphate)

Snippet

Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | Conditions: COVID-19, SARS-CoV Infection | Phase 2 | Status: COMPLETED